Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

34.89 -0.98 (-2.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about QuidelOrtho Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
QuidelOrtho® Introduces Results Manager™ System
From QuidelOrtho Corporation
Via Business Wire
Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including Lantheus (NASDAQ:LNTH) and its... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Reasons to Avoid QDEL and 1 Stock to Buy Instead
Over the last six months, QuidelOrtho’s shares have sunk to $40.10, producing a disappointing 7.7% loss - a stark contrast to the S&P 500’s 7.1% gain. This was partly due to its softer quarterly... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Earnings To Watch: Lantheus (LNTH) Reports Q4 Results Tomorrow
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings tomorrow before market hours. Here’s what you need to know. 
Via StockStory
Why QuidelOrtho Stock Bounced More Than 4% Higher Today
Via The Motley Fool
Where QuidelOrtho Stands With Analysts
Via Benzinga
Earnings Scheduled For February 12, 2025
Via Benzinga
QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference
From QuidelOrtho Corporation
Via Business Wire
Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings
Medical device company Penumbra (NYSE:PEN) will be reporting earnings tomorrow afternoon. Here’s what you need to know. 
Via StockStory
QuidelOrtho’s (NASDAQ:QDEL) Q4: Beats On Revenue But Full-Year Sales Guidance Misses Expectations
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q4 CY2024 results topping the market’s revenue expectations, but sales fell by 4.7% year on year to $707.8 million. On the other hand,... 
Via StockStory
Exposures COVID-19
QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Cracking The Code: Understanding Analyst Reviews For QuidelOrtho
Via Benzinga
QuidelOrtho Earnings: What To Look For From QDEL
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be announcing earnings results tomorrow afternoon. Here’s what to expect. 
Via StockStory
QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Announces Appointment of Two Independent Directors to its Board
From QuidelOrtho Corporation
Via Business Wire
Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted
QuidelOrtho's secondary offering of 8.26 million shares is priced at $38.58, removing an investor overhang, according to William Blair's analysis. 
Via Benzinga
Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Why Keysight Technologies Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group
From QuidelOrtho Corporation
Via Business Wire
Top 4 Health Care Stocks That May Plunge This Quarter
Via Benzinga
Smaller Cap Biotechs Are In Season: How Are We Doing?
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
QuidelOrtho Reports Third Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Participate in Three Upcoming Investor Conferences
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Report Third Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Announces New R&D Executive Leader
From QuidelOrtho Corporation
Via Business Wire
A Biotech Breakout Will Be Led By Small Caps
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever. 
Via Talk Markets
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
From QuidelOrtho Corporation
Via Business Wire
Why QuidelOrtho Stock Blasted 10% Higher Today
The healthcare company has significant and untapped earnings potential, asserts one pundit. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.